COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
Phage display derived monoclonal antibodies: from bench to bedside
MA Alfaleh, HO Alsaab, AB Mahmoud… - Frontiers in …, 2020 - frontiersin.org
Monoclonal antibodies (mAbs) have become one of the most important classes of
biopharmaceutical products, and they continue to dominate the universe of …
biopharmaceutical products, and they continue to dominate the universe of …
Bamlanivimab plus etesevimab in mild or moderate Covid-19
M Dougan, A Nirula, M Azizad… - … England Journal of …, 2021 - Mass Medical Soc
Background Patients with underlying medical conditions are at increased risk for severe
coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over …
coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over …
[HTML][HTML] COVID-19 vaccination for people with severe mental illness: why, what, and how?
V Mazereel, K Van Assche, J Detraux… - The Lancet …, 2021 - thelancet.com
Psychiatric disorders, and especially severe mental illness, are associated with an
increased risk of severe acute respiratory syndrome coronavirus 2 infection and COVID-19 …
increased risk of severe acute respiratory syndrome coronavirus 2 infection and COVID-19 …
[HTML][HTML] European cancer mortality predictions for the year 2022 with focus on ovarian cancer
Background Cancer mortality rates, though not absolute numbers of deaths, have been
decreasing over the last three decades in Europe. Materials and methods We estimated …
decreasing over the last three decades in Europe. Materials and methods We estimated …
[HTML][HTML] European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Background We predicted cancer mortality statistics for 2021 for the European Union (EU)
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
HJ Han, C Nwagwu, O Anyim, C Ekweremadu… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic which has induced …
syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic which has induced …
Perceived changes of specific attitudes, perceptions and behaviors during the Corona pandemic and their relation to wellbeing
A Büssing, D Rodrigues Recchia, R Hein… - Health and Quality of …, 2020 - Springer
Background During the COVID-19 pandemic, most people had to cope with the restrictions
of the lockdown, leaving them to their fears, insecurity and isolation. On the other hand, due …
of the lockdown, leaving them to their fears, insecurity and isolation. On the other hand, due …
Circulating microRNAs: Biomarkers of disease
Y Wu, Q Li, R Zhang, X Dai, W Chen, D Xing - Clinica Chimica Acta, 2021 - Elsevier
MicroRNAs are a class of endogenous noncoding single-stranded RNA molecules with
approximately 20–24 nucleotides and are associated with a broad range of biological …
approximately 20–24 nucleotides and are associated with a broad range of biological …
Real-world clinical outcomes of bamlanivimab and casirivimab-imdevimab among high-risk patients with mild to moderate coronavirus disease 2019
R Ganesh, LM Philpot, DM Bierle… - The Journal of …, 2021 - academic.oup.com
Background Bamlanivimab and casirivimab-imdevimab are authorized for treatment of mild
to moderate coronavirus disease 2019 (COVID-19) in high-risk patients. We compared the …
to moderate coronavirus disease 2019 (COVID-19) in high-risk patients. We compared the …